Skip to content

Comparison of Ultrasound Guided Saphenous Nerve Block using Two Different Anatomical Approaches in patients undergoing knee surgery

Comparison of the analgesic efficacy and onset time of the ultrasound-guided saphenous nerve block using two different anatomical approach that one of them is subsartorial and the other is level of medial condylar, addition to sciatic nerve block in all patients undergoing knee surgery.

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12614000057684
Enrollment
60
Registered
2014-01-20
Start date
2014-01-31
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The present study was designed to compare and evaluate to applicable the ultrasound guided saphenous nerve blocks which are supsartorial approach and medial condyl approach, and measure to onset time, block duration time, patient satisfaction. Sixty patients between 18 to 60 years of age undergoing sub-knee surgery were randomized to two groups. Intervention(s): Saphenous nerve block performs using the ultrasound-guided technique with 5 mL 0.25 % levobupivacaine+ %1 lidocaine with either subsartorial tecnique or medial condyl tecnique. Main outcome measures: Blocks duration time, block onset time and patient satisfaction over the course of 24 hours.

Interventions

We apply Ultrasound guided saphenous nerve block at level of medial condyl with 5 mL % 0.25 levobupivacaine + % 1 lidocaine for intraoperative anaesthesia management undergoing sub-knee surgery

Sponsors

Levent Sahin
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

American Society of Anesthesiologist (ASA) class I-III patients who were scheduled for sub-knee surgery

Exclusion criteria

Psychiatric illness, Diabetes mellitus, any organ failure and known hypersensitivity to relevant drugs.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026